메뉴 건너뛰기
Lancet Neurology
Volumn 5, Issue 12, 2006, Pages 994-996
NICE and anti-dementia drugs: a triumph of health economics over clinical wisdom?
Author keywords

[No Author keywords available]
Indexed keywords

DONEPEZIL; GALANTAMINE; RIVASTIGMINE;
EID: 33750717831     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70607-X     Document Type: Letter
Times cited : (8)
References (6)
  • 1
    • 0036850937 scopus 로고    scopus 로고
    • Dementia Care Mapping as a research tool for measuring quality of life in care settings: psychometric properties
    • Fossey J., Lee L., and Ballard C. Dementia Care Mapping as a research tool for measuring quality of life in care settings: psychometric properties. Int J Geriatr Psychiatry 17 (2002) 1064-1070
    • (2002) Int J Geriatr Psychiatry , vol.17 , pp. 1064-1070
    • Fossey, J.1    Lee, L.2    Ballard, C.3
  • 2
    • 18144388713 scopus 로고    scopus 로고
    • Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology
    • Smith S., Lamping D., Banerjee S., Harwood R., Foley B., and Smith P. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess 9 (2005) 10
    • (2005) Health Technol Assess , vol.9 , pp. 10
    • Smith, S.1    Lamping, D.2    Banerjee, S.3    Harwood, R.4    Foley, B.5    Smith, P.6
  • 3
    • 0035433877 scopus 로고    scopus 로고
    • EQ-5D in patients with dementia: an investigation of inter-rater agreement
    • Coucill W., Bryan S., Bentham P., Buckley A., and Laight A. EQ-5D in patients with dementia: an investigation of inter-rater agreement. Med Care 39 (2001) 760-771
    • (2001) Med Care , vol.39 , pp. 760-771
    • Coucill, W.1    Bryan, S.2    Bentham, P.3    Buckley, A.4    Laight, A.5
  • 4
    • 0035949734 scopus 로고    scopus 로고
    • Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada
    • Getsios D., Caro J., Caro G., Ishak K., and Group A. Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada. Neurology 57 (2001) 972-978
    • (2001) Neurology , vol.57 , pp. 972-978
    • Getsios, D.1    Caro, J.2    Caro, G.3    Ishak, K.4    Group, A.5
  • 5
    • 0032603374 scopus 로고    scopus 로고
    • Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers
    • Neumann P., Kuntz K., Leon J., et al. Health utilities in Alzheimer's disease: a cross-sectional study of patients and caregivers. Med Care 37 (1999) 27-32
    • (1999) Med Care , vol.37 , pp. 27-32
    • Neumann, P.1    Kuntz, K.2    Leon, J.3
  • 6
    • 0031883716 scopus 로고    scopus 로고
    • A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
    • Rogers S., Farlow M., Doody R., Mohs R., and Friedhoff L. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 50 (1998) 136-145
    • (1998) Neurology , vol.50 , pp. 136-145
    • Rogers, S.1    Farlow, M.2    Doody, R.3    Mohs, R.4    Friedhoff, L.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.